Literature DB >> 26298577

Hypoxia-inducible factors regulate T cell metabolism and function.

Anthony T Phan1, Ananda W Goldrath2.   

Abstract

Resolution of infection requires the coordinated response of heterogeneous cell types to a range of physiological and pathological signals to regulate their proliferation, migration, differentiation, and effector functions. One mechanism by which immune cells integrate these signals is through modulating metabolic activity. A well-studied regulator of cellular metabolism is the hypoxia-inducible factor (HIF) family, the highly conserved central regulators of adaptation to limiting oxygen tension. HIF's regulation of cellular metabolism and a variety of effector, signaling, and trafficking molecules has made these transcription factors a recent topic of interest in T cell biology. Low oxygen availability, or hypoxia, increases expression and stabilization of HIF in immune cells, activating molecular programs both unique and common among cell types, including glycolytic metabolism. Notably, numerous oxygen-independent signals, many of which are active in T cells, also result in enhanced HIF activity. Here, we discuss both oxygen-dependent and -independent regulation of HIF activity in T cells and the resulting impacts on metabolism, differentiation, function, and immunity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Differentiation; Hypoxia-inducible factor; Immunity; Metabolism; T cell

Mesh:

Substances:

Year:  2015        PMID: 26298577      PMCID: PMC4679538          DOI: 10.1016/j.molimm.2015.08.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  77 in total

1.  Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing.

Authors:  N S Chandel; D S McClintock; C E Feliciano; T M Wood; J A Melendez; A M Rodriguez; P T Schumacker
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability.

Authors:  Gerritje J W van der Windt; David O'Sullivan; Bart Everts; Stanley Ching-Cheng Huang; Michael D Buck; Jonathan D Curtis; Chih-Hao Chang; Amber M Smith; Teresa Ai; Brandon Faubert; Russell G Jones; Edward J Pearce; Erika L Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

3.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

Authors:  Madhusudhanan Sukumar; Jie Liu; Yun Ji; Murugan Subramanian; Joseph G Crompton; Zhiya Yu; Rahul Roychoudhuri; Douglas C Palmer; Pawel Muranski; Edward D Karoly; Robert P Mohney; Christopher A Klebanoff; Ashish Lal; Toren Finkel; Nicholas P Restifo; Luca Gattinoni
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 4.  Fueling immunity: insights into metabolism and lymphocyte function.

Authors:  Erika L Pearce; Maya C Poffenberger; Chih-Hao Chang; Russell G Jones
Journal:  Science       Date:  2013-10-11       Impact factor: 47.728

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch.

Authors:  Patrick M Gubser; Glenn R Bantug; Leyla Razik; Marco Fischer; Sarah Dimeloe; Gideon Hoenger; Bojana Durovic; Annaïse Jauch; Christoph Hess
Journal:  Nat Immunol       Date:  2013-08-18       Impact factor: 25.606

8.  Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect.

Authors:  Fan Yang; Huafeng Zhang; Yide Mei; Mian Wu
Journal:  Mol Cell       Date:  2013-12-05       Impact factor: 17.970

9.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

10.  Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.

Authors:  Andrew L Doedens; Anthony T Phan; Martin H Stradner; Jessica K Fujimoto; Jessica V Nguyen; Edward Yang; Randall S Johnson; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2013-09-29       Impact factor: 25.606

View more
  27 in total

Review 1.  Redox regulation of immunometabolism.

Authors:  Jonathan Muri; Manfred Kopf
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

2.  Constitutive Glycolytic Metabolism Supports CD8+ T Cell Effector Memory Differentiation during Viral Infection.

Authors:  Anthony T Phan; Andrew L Doedens; Asis Palazon; Petros A Tyrakis; Kitty P Cheung; Randall S Johnson; Ananda W Goldrath
Journal:  Immunity       Date:  2016-11-08       Impact factor: 31.745

3.  Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.

Authors:  Yana G Najjar; Ashley V Menk; Cindy Sander; Uma Rao; Arivarasan Karunamurthy; Roma Bhatia; Shuyan Zhai; John M Kirkwood; Greg M Delgoffe
Journal:  JCI Insight       Date:  2019-03-07

Review 4.  Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis.

Authors:  Calen A Steiner; Ian M Cartwright; Cormac T Taylor; Sean P Colgan
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

5.  Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.

Authors:  Nicole E Scharping; Ashley V Menk; Ryan D Whetstone; Xue Zeng; Greg M Delgoffe
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

Review 6.  Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.

Authors:  Dayana B Rivadeneira; Greg M Delgoffe
Journal:  Clin Cancer Res       Date:  2018-01-31       Impact factor: 12.531

7.  Hypoxia and Innate Immunity: Keeping Up with the HIFsters.

Authors:  Sean P Colgan; Glenn T Furuta; Cormac T Taylor
Journal:  Annu Rev Immunol       Date:  2020-01-21       Impact factor: 28.527

8.  CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.

Authors:  Sara Labiano; Florinda Meléndez-Rodríguez; Asís Palazón; Álvaro Teijeira; Saray Garasa; Iñaki Etxeberria; M Ángela Aznar; Alfonso R Sánchez-Paulete; Arantza Azpilikueta; Elixabet Bolaños; Carmen Molina; Hortensia de la Fuente; Patricia Maiso; Francisco Sánchez-Madrid; Manuel Ortiz de Landázuri; Julián Aragonés; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

Review 9.  Targeting metabolism to reverse T-cell exhaustion in chronic viral infections.

Authors:  John D Sears; Kevin J Waldron; Jian Wei; Chih-Hao Chang
Journal:  Immunology       Date:  2020-08-11       Impact factor: 7.397

Review 10.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.